MTCH
44
-2
ADBE
45
10
MET
66
6
CSX
36
3
MDT
57
-3
GOOGL
45
5
FFIV
57
3
MDLZ
55
-10
HRL
38
-7
IFF
41
-3
AEE
71
-2
MPC
33
3
CB
50
-5
IVZ
35
-4
ED
56
-3
EBAY
42
2
AVGO
22
4
ICE
69
3
DVN
35
14
OMC
51
-4
MTCH
44
-2
ADBE
45
10
MET
66
6
CSX
36
3
MDT
57
-3
GOOGL
45
5
FFIV
57
3
MDLZ
55
-10
HRL
38
-7
IFF
41
-3
AEE
71
-2
MPC
33
3
CB
50
-5
IVZ
35
-4
ED
56
-3
EBAY
42
2
AVGO
22
4
ICE
69
3
DVN
35
14
OMC
51
-4
Financhill
Back

Neurogene Stock Predictions

Should You Invest in this AI Marketing High-Growth Startup by April?

Invest Now & Secure Your Stake in RAD Intel
Sell
41

NGNE
Neurogene

Last Price:
$17.88
Seasonality Move:
-6.2%

7 Day Trial

ALL ACCESS PASS

$ 7

The Tariff-Proof Asset in Your Pocket

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Neurogene Stock Forecast

  • Over the next 52 weeks, Neurogene has on average historically risen by 36.6% based on the past 11 years of stock performance.
  • Neurogene has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%
  • Is Neurogene Stock Undervalued?
    The current Neurogene [NGNE] share price is $17.78. The Score for NGNE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Neurogene Stock Go Up Next Year?

  • Over the next 52 weeks, Neurogene has on average historically risen by 36.6% based on the past 11 years of stock performance.

Neurogene Stock Rating

Sell
41
Neurogene (NGNE) is a Sell

Is Neurogene overpriced?

  • Neurogene has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%

Neurogene Stock Price History

Is NGNE stock going to rise?

  • The current trend is relatively stagnant and NGNE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com

52-Week Data

52-Week High:
74.49
52-Week Low:
14.42

Prediction Charts

Market Cap:
264.1M
Price in USD:
17.78
Volume:
119.4K
Beta:
-1.34

Technical Analysis

SMA50:
18.53
SMA100:
27.70
SMA200:
33.02
52-Wk Change:
-51.07%

Stock Predictions

  • Is Neurogene stock public?
    Yes, Neurogene is a publicly traded company.
  • What is the Neurogene stock quote today?
    The Neurogene stock price is 17.78 USD today.
  • How to buy Neurogene stock online?
    You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-19 17.07 16.97 17.80 16.96
Feb-20 16.89 17.31 17.55 16.72
Feb-21 17.53 17.33 17.91 16.95
Feb-25 16.45 16.86 16.93 16.04
Feb-26 16.80 17.20 17.31 16.65
Feb-27 17.20 17.13 17.70 16.73
Feb-28 17.18 17.69 17.76 16.54
Mar-3 17.78 16.25 17.78 16.21
Mar-4 16.03 16.31 16.51 15.69
Mar-5 16.10 16.94 17.31 16.08
Mar-6 16.61 16.68 16.99 16.24
Mar-7 16.80 17.28 17.48 16.44
Mar-11 17.06 17.67 17.93 16.76
Mar-12 18.12 17.78 18.62 17.45

Neurogene Earnings

Neurogene Earnings Report: Per Share Neurogene Earnings Q1 Q2 Q3 and Q4 last year and next year.

Neurogene Forecast Revenue Growth

Neurogene Stock Analysis: Historical quarterly revenues per share for Neurogene and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.00 per share.

* Neurogene stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.